Taking to Twitter, Bollywood celebrities applauded the scientists and doctors for their achievement.
Share Via Email
| A+A A-
Celebrities like Nimrat Kaur and Parambrata Chatterjee welcomed the government s vaccination drive. (Photo| PTI and IMDb) By PTI
MUMBAI: As Prime Minister Narendra Modi on Saturday launched India s COVID-19 vaccination drive, many from the Indian film industry took to social media to recognise the efforts of scientists, doctors and healthcare workers.
The Drugs Controller General of India (DCGI) had earlier this month approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.
Read more about Dr. Reddys receives DCGI approval to conduct Phase 3 clinical trial for Sputnik V vaccine in India on Business Standard. The phase 3 study of Sputnik V will be conducted on 1500 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India.
DCGI needs communication strategy on COVID-19 approvals: WHO s Swaminathan
World Health Organization (WHO) chief scientist, Dr. Soumya Swaminathan s comments come in the backdrop of several Indian vaccine makers and medical experts complaining about the confusing manner in which DCGI has granted emergency use approvals for COVID-19 vaccines in India
Joe C Mathew | January 11, 2021 | Updated 12:53 IST
On India s preparations for the COVID-19 vaccine rollout,World Health Organization (WHO) chief scientist, Dr. Soumya Swaminathan said the country has done a good job
India is well prepared for the vaccine rollout. However, the Indian drug regulator - Drugs Controller General of India - should have a communication package that goes along with the emergency use approvals (EUA) given for COVID-19 vaccines, says World Health Organization s (WHO) chief scientist, Dr. Soumya Swaminathan.
BW Businessworld
Vaccine: A Mother of All Doses
All conversations have come to be centred around the Covid-19 vaccine – from the extent and pace of the economic recovery that it is expected to help foster to its very own safety and efficacy
Photo Credit :
Act I, Part I: Once upon a time, in Wuhan in the Hubei province of China, someone got very sick, and the ailment was identified as Covid-19. And then, it made more and more people sick every day, in Wuhan and in other parts of the world, quickly turning into a pandemic. Tens of millions came to be afflicted by the deadly coronavirus, in country after country, including India, with more than two million people succumbing to it. Today, more than a year since the first case surfaced, tens of thousands of new cases continue to be reported from different parts of the globe, fuelling neverending conversations around Covid.
Full authorisation for Covid vaccines 12 months after Phase III: WHO s Swaminathan
Full authorisation-better known as full pre-qualification -is a pre-requisite to sell the vaccine in the open market or for mass immunisation of healthy individuals who are not frontline workers
At least 13 vaccine manufacturers have approached World Health Organisation (WHO) for approval, says the organization s Chief Scientist Dr Soumya Swaminathan
Full-fledged authorisation for coronavirus vaccines can be granted only after 12 months of follow-up on efficacy and safety from the date of presentation of the Phase III clinical trials data, says World Health Organization s Chief Scientist Dr Soumya Swaminathan.
At least 13 vaccines are in various states of trials across the world while 6 of them are vying to be the first to get Full authorisation, including Pfizer, Moderna, AstraZeneca-Serum-Oxford, Bharat Biotech, Gamaleya and Sinopharm.